Filtros de búsqueda

Lista de obras de

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

scientific journal article

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

scientific journal article

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

artículo científico publicado en 2017

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.

artículo científico publicado en 2011

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

artículo científico publicado en 2010

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation ⬇️

artículo científico publicado en 2016

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

artículo científico publicado en 2017

Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

scientific article published on 15 July 2018

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

scientific article published on 01 June 2002

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

artículo científico publicado en 2004

Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL

scientific article published on 08 November 2019

Is venetoclax a new wonder drug in CLL?

scientific article published on 11 March 2019

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

artículo científico publicado en 2017

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality

artículo científico publicado en 2002

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL. ⬇️

artículo científico publicado en 2017

Telomere fusions associate with coding sequence and copy number alterations in CLL

artículo científico publicado en 2019

Telomere length is an independent prognostic marker in MDS but not in de novo AML.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda